Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)

v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Revenues:        
License and collaborative fees $ 645 $ 2,450 $ 1,852 $ 4,615
Contract and other 1,429 2,686 5,412 9,903
Total revenues 2,074 5,136 7,264 14,518
Operating expenses:        
Research and development 17,559 20,235 57,255 61,371
Selling, general and administrative 5,632 5,354 15,913 15,768
Restructuring 2,561   2,561 84
Total operating expenses 25,752 25,589 75,729 77,223
Loss from operations (23,678) (20,453) (68,465) (62,705)
Other income (expense):        
Interest expense (1,030) (1,060) (3,152) (3,295)
Other income (expense), net (194) 1,393 1,453 1,332
Revaluation of contingent warrant liabilities 24,422 5,721 24,206 33,685
Net loss $ (480) $ (14,399) $ (45,958) $ (30,983)
Basic net loss per share of common stock (in dollars per share) $ 0.00 $ (0.13) $ (0.39) $ (0.29)
Diluted net loss per share of common stock (in dollars per share) $ 0.00 $ (0.17) $ (0.39) $ (0.55)
Shares used in computing basic net loss per share of common stock (in shares) 118,552 107,208 117,437 106,768
Shares used in computing diluted net loss per share of common stock (in shares) 118,552 114,323 117,437 114,876
Other comprehensive loss:        
Net loss $ (480) $ (14,399) $ (45,958) $ (30,983)
Net unrealized (loss) gain on available-for-sale securities   (2)   5
Comprehensive loss $ (480) $ (14,401) $ (45,958) $ (30,978)